-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Acadia Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $31.6M.
- Acadia Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $112M.
- Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$73.4M, a 67.2% increase from 2022.
- Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$224M, a 31.2% decline from 2021.
- Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$170M, a 40.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)